NewsRoom Articles - Page 47 of 154 - PsychedelicNewsWire (PNW)

ThursdayOct 06, 2022 1:37 pm

Researchers Develop Psychedelic Compound with No Hallucinogenic Effects, Can Treat Depression

About five years ago, researchers started a trial looking into the therapeutic effects of psilocybin. This compound is the active ingredient found in hallucinogenic mushrooms, and it induces a high when ingested. The trial involved patients suffering from cancer-related depression. Each of the patients in the trial received a dose of this psychedelic, which was accompanied with a session led by certified and trained therapists. Several months later, 80% of the study’s participants were found to be considerably less depressed. Since then, other trials have discovered similar long-lasting benefits in patients with depression. Different anecdotal reports suggest that psychedelics may…

WednesdayOct 05, 2022 11:29 am

VA Closely Watching Developments in Psychedelic Space

Last week, a VA official told the House Veterans’ Affairs Committee that the Department of Veterans Affairs (VA) was closely monitoring studies into the therapeutic potential of psychedelic substances. During the hearing, Rep. Colin Allred talked about his interest in alternative treatments such as psilocybin and MDMA for military veterans who suffered from a variety of conditions, including post-traumatic stress disorder as well as other suicide risk factors. The congressman also asked Lisa Brenner, a clinical researcher at the Veterans Health Administration, about the status of research into alternative therapies, given findings from studies showing psychedelics held potential in the…

WednesdayOct 05, 2022 10:30 am

Silo Pharma Inc. (NASDAQ: SILO) Successfully Uplists, Commences Trading on the Nasdaq Market

Silo Pharma, Inc recently uplisted to the Nasdaq Capital Market, raising gross proceeds of $5 million The biopharmaceutical company has sought to merge traditional therapeutics and psychedelic research, entering into a series of joint ventures with leading medical universities to carry out research into the field Meanwhile, psychedelics are gaining increasing favour within the United States with Oregon set to begin allowing the supervised usage of psilocybin from 2023 onwards Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused around merging traditional therapeutics with psychedelic research, recently announced that it had successfully priced its fully underwritten initial public offering,…

TuesdayOct 04, 2022 11:40 am

How Psychedelic Integration Coaches Help Facilitate Healing

The psychiatry space is all abuzz with excitement about psychedelic-assisted psychotherapy. In recent years, numerous studies have found that psychedelics may be effective in the treatment of a range of mental health conditions, including PTSD and depression as well as eating disorders. When paired with psychotherapy, these psychedelic treatments can deliver profound and long-term improvements. Through the psychedelic experience, patients have been able to come to terms with traumatic memories and develop new positive outlooks on life. This experience involves consuming a psychedelic in the presence of a professional psychotherapist who guides the patient through the trip. Once the experience…

MondayOct 03, 2022 10:50 am

How to Identify Good Psychedelics Research from the Rest

We have seen interest in psychedelics grow these last few years as societal attitudes toward the use of these drugs change and their purported benefits for mental-health conditions make headlines. While learning more about this topic and the advancements being made is interesting, it is important to learn to differentiate between good research and unreliable research. First of all, you should examine your source. Reliable scientific research is usually published in peer-reviewed scientific journals. Peer-reviewed research is usually read and criticized by qualified and independent experts. If the journal containing the study you’re reading doesn’t support peer reviewing, then chances…

FridaySep 30, 2022 12:12 pm

What Do We Know About Psychedelics and Grief?

Similar to grief, psychedelics can create profound experiences by inducing change through intense responses to emotional stimuli. Grief and psychedelics are said to be similar, because they are both enveloped in folklore mysticism and societal taboos. Additionally, they are both a natural, ancient and delicate human experience. Thus far, we know that grief is a bodily and emotional traumatic event that can rewire an individual’s brain, similar to post-traumatic stress disorder. When an individual forms a bond with another person, changes in how some proteins are folded in the brain’s nucleus accumbens occur. The nucleus accumbens is responsible for stress,…

ThursdaySep 29, 2022 12:08 pm

Could Psychedelics Help Veterans Suffering from Chronic Pain?

Over the last decade, VA hospitals in Canada have been nexuses for randomized, controlled trials on the use of psychedelics in the treatment of conditions such as depression, anxiety and post-traumatic stress disorder (PTSD). This is mainly because veterans are more likely to suffer from these conditions in comparison to the overall population. Additionally, it is because VA hospitals offer controlled environments, which are ideally suited for running such trials. These trials have afforded researchers useful information on the safety and effectiveness of using psychedelics in the treatment of a range of psychiatric problems, including anxiety, post-traumatic stress disorder, alcohol…

WednesdaySep 28, 2022 1:04 pm

Psychedelics Feature During Congressional Ways and Means Committee Meeting

Last week, Rep. Earl Blumenauer discussed the therapeutic potential of psychedelic drugs as alternatives to traditional drugs for mental health disorders during a House Ways and Means Committee meeting. During the meeting, legislators talked about proposals on family and worker access to health support. The congressman stated that while he was encouraged by how legislators were moving forward with integrating various reform areas, including outpatient care, there was still a need to advance the search for therapies that could help to better manage mental health conditions; he proposed that psychedelics be included in the healthcare improvements discussion. His statement was…

TuesdaySep 27, 2022 12:00 pm

Ancillary Firms to Play Bigger Role in Psychedelics Space

For a while now, researchers have been conducting studies on psychedelics, gathering more knowledge on these substances and their benefits. Prior research has demonstrated that psychedelics could help manage anxiety, treatment-resistant depression and post-traumatic stress disorder for individuals who haven’t benefitted from the currently prescribed medications. As the psychedelics space grows, so do investments into the market. Unsurprisingly, the number of nondrug startups involved in the space has increased considerably, moving from 19% in 2020 to 38% in 2021. However, with the market reaching oversaturation and funding for biotech startups drying up, many believe that ancillary tech firms will be…

MondaySep 26, 2022 12:00 pm

An Analysis of Psychedelics in End-of-Life Care

Psychedelics are slated to disrupt psychiatry in a major way. Although there is limited research on the possible benefits of hallucinogenic drugs, recent studies have found that they can have significant mental health benefits. Researchers have discovered that when paired with psychotherapy, psychedelics can deliver profound benefits for people with mental health conditions, including PTSD, anxiety, depression and eating disorders. Specifically these mental health benefits, especially against anxiety and depression, can come in handy for patients in palliative or end-of-life care. Receiving a terminal diagnosis often results in feelings of grief, anxiety and depression. According to researchers from Baylor University…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000